[ Aphea.Bio raises $10.1M in Series A ]
Aphea.Bio has raised $10.1 million in Series A funding.
Founded in 2017, Aphea.Bio is engaged in the development of biopesticides to protect agricultural products from fungal diseases.
Aphea.Bio will also develop novel ‘biostimulants,’ with the aim of stimulating crop growth through various processes, such as promoting the uptake of nutrients from the soil.
|Founder / CEO||Isabel Vercauteren|
|Investors||Gemma Frisius Fund KU Leuven|
|Group De Ceuster|
|Agri Investment Fund|